Friday, October 30, 2026
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
  • Home
  • News
    • Foreign
    • Crime
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates
No Result
View All Result
Freedom Online
No Result
View All Result

UTME: Institutions to begin first, second choice admissions August 21

Roland Edwards by Roland Edwards
July 20, 2020
in Breaking News, Education, News
0
JAMB

JAMB

Share on FacebookShare on TwitterShare on Whatsapp

The Joint Admissions and Matriculation Board (JAMB) has directed all tertiary institutions to begin the conduct of the first and second choice admissions from August 21.

The board gave the directive in the 2020 admission guidelines released in Abuja by the board spokesperson, Dr Benjamin Fabian.

Fabian, in the guidelines, warned institutions against duplication of forms, adding that they should desist from selling forms for admissions into some listed programmes.

He urged institutions to advise candidates to apply for the programmes through its office, saying that all admission exercise must be conducted on the Central Admission Processing System.

“All applications for admissions to First Degree, National Diploma, National Innovation Diploma and the Nigeria Certificate in Education into full-time, distance learning, part-time, outreach, sandwich, etc, must be processed only through JAMB.

”Institutions that desire to place advertisement can do so by advising candidates who applied for the current Unified Tertiary Matriculation Examination to change to their institution as first choice rather than requesting the candidates to purchase another application form or apply.

”This is to prevent the issue of double registration which is a violation of the JAMB mandate,” he said.

Tags: UTME: Institutions to begin first second choice admissions August 21
Share25Tweet16Send
Previous Post

Messi breaks top goalscorer record after Barca’s final day win

Next Post

Coronavirus vaccine: WHO Chief Scientist thinks mid-2021 is possible

Next Post
WHO: New COVID-19 cases slowing down

Coronavirus vaccine: WHO Chief Scientist thinks mid-2021 is possible

N40bn NDDC probe: Reps Committee Chairman steps down

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

https://freedomonline.com.ng/wp-content/uploads/2026/04/VID-20260408-WA0025.mp4
https://freedomonline.com.ng/wp-content/uploads/2025/01/5aeac180-db4e-4e7c-bd37-07ddbf15b053.mp4

Popular Stories

Plugin Install : Popular Post Widget need JNews - View Counter to be installed

Latest Stories

46-year-old Ondo businessman, Kayode Akinbolusere, records video about life struggles, commits suicide

October 30, 2026

Sanwo-Olu recalls ‘how Hamzat stepped aside for me to become governor in 2019’, describes his deputy as ‘a trusted partner, worthy successor’

October 30, 2026
Sowore

Police: We rescued Sowore from ‘some individuals at a restaurant’

October 30, 2026

With seven pillars, 31 chapters and 100 pledges, APC guber candidate, Hamzat​,‌‍‌‌ ​unveils development agenda for Lagos

October 30, 2026
Samson Adamu

Mutfwang congratulates Samson Adamu on appointment as CAF General Secretary

October 30, 2026

Why North-Central Has Yet to Produce Nigeria’s Elected President — Segun Showun

October 30, 2026

Nigeria Seeks More Funding for World Court, Cites Cameroon Border Settlement

October 30, 2026
Freedom Online

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.

Navigate Site

  • Home
  • News
  • Business
  • Politics
  • Health
  • Entertainment
  • Interview
  • Sports
  • Ad Rates

Follow Us

No Result
View All Result

© 2026 Published by SWAAYA LIMITED, Plot 20, Block G, Scheme 1, Residential 3, OPIC Beachland Estate, Lagos/Ibadan Expressway, Lagos. Gabriel Akinadewo, MD/CEO 08023010222, 08094000056, 08052097814.